Humana (HUM)
(Delayed Data from NYSE)
$255.57 USD
-2.03 (-0.79%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $256.00 +0.43 (0.17%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum B VGM
Price, Consensus and EPS Surprise
HUM 255.57 -2.03(-0.79%)
Will HUM be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HUM
UnitedHealth Pre-Q3 Earnings: Golden Opportunity or Fool's Gold?
Is Humana a Deep Value Stock to Buy?
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Humana Stock Getting Closer to 52-Week Lows: A Buying Opportunity?
Company News for Oct 3, 2024
Humana and Interwell Health Expand Value-Based Support to Florida
Other News for HUM
10 Health Care Stocks With Whale Alerts In Today's Session
Market Whales and Their Recent Bets on HUM Options
Rising Healthcare Costs Impact UnitedHealth's Earnings Outlook
UnitedHealth drags rivals as 2025 outlook disappoints
UnitedHealth dips as cost concerns weigh on insurance unit